Our firm brings deep resources, trial experience, and decades of proven success to achieve precedent-setting outcomes in complex securities litigation and arbitration that protect the rights of investors. Girard Sharp lawyers have successfully represented thousands of investors in a wide range of financial and investment fraud matters, including investments in public securities markets, private offerings, non-traded REITs, and major financial fraud cases. With more than $1.2 billion recovered for clients, we combine strategic insight, rigorous analysis, and relentless advocacy to hold wrongdoers accountable and recover losses for investors.
We serve as co-lead counsel in a certified securities class action on behalf of investors of DXC Technology Company (NYSE: DXC), regarding alleged violations of federal securities laws for material misstatements and omissions associated with DXC’s workforce optimization plans. The court granted preliminary approval of a $47.5 million settlement in December 2025.
We served as co-lead counsel in a securities class action on behalf of GWG Holdings, Inc. bond investors, alleging violations of federal securities laws relating to GWG’s financial accounting for its interest in an affiliate. $50.95 million settlement approved in January 2026.
In deciding whether to initiate a securities class action or pursue other means to resolve a dispute, our approach is clear and client-focused. Each case is carefully analyzed and prepared as if it were headed to trial, ensuring we are well-equipped to reach a favorable settlement or present a compelling case before a judge or jury.
Judges have recognized our experience in securities litigation, naming us lead counsel in major securities fraud cases on behalf of a variety of institutional investors. We have appeared on behalf of a range of clients, including the California Teachers’ Retirement System, the Kansas Public Employees Retirement System, Allianz of America, Fireman’s Fund Insurance Company, family offices, and high-net-worth individuals.
Girard Sharp is investigating potential claims on behalf of Inspired Healthcare Capital investors who have experienced delays or suspensions of distributions.
Girard Sharp is investigating potential securities claims on behalf of Oracle Corporation investors who purchased senior notes or bonds issued on September 25, 2025.
Girard Sharp is investigating potential securities claims on behalf of former investors of The AZEK Company (“AZEK”) who received shares of James Hardie Industries plc (“James Hardie” or the “Company”) in connection with James Hardie’s acquisition of AZEK on July 1, 2025 (“Merger”).
Girard Sharp served as co-lead counsel in a certified securities class action on behalf of investors of Maxar Technologies, Ltd. (NYSE: MAXR) regarding alleged violations of federal securities laws for material misstatements and omissions associated with the performance and economic outlook of one of its core business units. The court granted preliminary approval of a $36.5 million settlement in June 2023.
Girard Sharp served as lead counsel in a consolidated class action brought on behalf of investors against a major bank for furthering a Ponzi scheme. After several years of litigation in bankruptcy court and district court, the parties reached a $54.5 million settlement approved by the court in December 2021.
Girard Sharp served as an Executive Committee member in the largest EB-5 fraud in the history of the United States, involving more than 800 foreign investors owed over $400 million. The firm helped to secure a $150 million recovery from Raymond James and additional recoveries from other parties.